Meixin Da (美新达)美新达
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 江苏迪赛诺制药有限公司Chinese legal name: 江苏迪赛诺制药有限公司
主要成分Active Ingredients
- 马吲哚Mayin Duo
药物知识说明
马吲哚是一种在国家药监局注册认定的药品。标注生产企业为江苏迪赛诺制药有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：江苏迪赛诺制药有限公司Chinese legal name: 江苏迪赛诺制药有限公司、江苏迪赛诺制药有限公司Chinese legal name: 江苏迪赛诺制药有限公司、江苏迪赛诺制药有限公司Chinese legal name: 江苏迪赛诺制药有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 美新达) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 江苏迪赛诺制药有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 江苏迪赛诺制药有限公司Chinese legal name: 江苏迪赛诺制药有限公司, 江苏迪赛诺制药有限公司Chinese legal name: 江苏迪赛诺制药有限公司, 江苏迪赛诺制药有限公司Chinese legal name: 江苏迪赛诺制药有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 美新达Recorded Chinese name: 美新达
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 1mg1 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 江苏迪赛诺制药有限公司Chinese legal name: 江苏迪赛诺制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H10960054
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H10960054
Manufacturer
Chinese legal name: 江苏迪赛诺制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H10960054
生产企业
江苏迪赛诺制药有限公司(国产)
适应症
食欲抑制剂，适用于治疗非器质性单纯性肥胖症，以辅助控制饮食及运动疗法的减肥作用。
用法用量
1.口服：一般剂量为一次0.5mg，一日1次，饭前服用。|2.一日最大剂量不超过1.5mg，分2～3次饭前服用，8～12周为一个疗程。
不良反应
偶尔有口干、头痛、神经过敏、恶心、便秘、失眠、心动过速、皮疹、排尿及月经失调、性功能可逆性障碍等报道。
禁忌
1.对本品过敏者禁用。|2.严重肾、肝、心功能不全及心律不齐、严重高血压，兴奋过度者和青光眼患者禁用。|3.服用同时禁服神经元阻断型降压药，如胍乙啶、贝坦尼啶等；服用单胺氧化酶抑制剂期间或用后二周内不得服用。|4.因器质性病变引起肥胖禁用。
注意事项
1.糖尿病患者使用可能影响胰岛素及降血糖药物效果，故在治疗期间应监测患者代谢状况，必要时应适当调整胰岛素及降糖药物剂量。高血压患者使用时，应注意血压监测。|2.可能增加外源性儿茶酚胺效应，故使用肾上腺素类药物应密切监测患者心血管系统反应。|3.具有兴奋作用，司机或操纵机器者慎用。4.不得超过规定最高服药量以试图增效，正常疗程一般为2～3个月，部分病例较短疗程已显效。服用前后宜作血象、肝、肾功能检查。
贮藏
密封，置阴凉处。
规格
1mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.